Then we performed GSEA analysis to study the biological functions of differential methylation sites in KIRC patients and found that those differential methylation sites were significantly enriched in tumor angiogenesis, vascular endothelial growth factor A (VEGFA), immune, TP53 targets, and hypoxia-associated pathways (Fig. 6b, c). This evidence concerns the gene TP53 and neoplasm.